Home › Sezary Syndrome › California › Mountain View
Sezary Syndrome clinical trials in Mountain View, CA
5 studies for Sezary Syndrome are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Stanford University School of Medicine, Stanford · 5 mi away
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
RecruitingObservational study
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi away
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
RecruitingPhase 2
- Stanford Cancer Center, Stanford · 5 mi away
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Stanford University Medical Center (Data collection only), Stanford · 5 mi away
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
RecruitingPhase 2
- Stanford University Medical Center, Stanford · 5 mi away
Sezary Syndrome trials in other cities
- Baldwin Park, CA7 studies
- Boston, MA4 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Tampa, FL3 studies
- Philadelphia, PA3 studies
- St. Louis, MO3 studies
- Pittsburgh, PA3 studies
Other studies in Mountain View
- Cancer (all types)40 studies
- Breast Cancer26 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Prostate Cancer15 studies
- Heart Failure15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.